"Neutropenia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A decrease in the number of NEUTROPHILS found in the blood.
Below are MeSH descriptors whose meaning is more general than "Neutropenia".
Below are MeSH descriptors whose meaning is more specific than "Neutropenia".
This graph shows the total number of publications written about "Neutropenia" by people in Harvard Catalyst Profiles by year, and whether "Neutropenia" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 4 | 8 | 12 |
| 1994 | 4 | 9 | 13 |
| 1995 | 5 | 6 | 11 |
| 1996 | 4 | 11 | 15 |
| 1997 | 2 | 9 | 11 |
| 1998 | 6 | 4 | 10 |
| 1999 | 6 | 7 | 13 |
| 2000 | 6 | 18 | 24 |
| 2001 | 3 | 10 | 13 |
| 2002 | 3 | 13 | 16 |
| 2003 | 5 | 6 | 11 |
| 2004 | 3 | 11 | 14 |
| 2005 | 6 | 14 | 20 |
| 2006 | 7 | 10 | 17 |
| 2007 | 7 | 7 | 14 |
| 2008 | 7 | 5 | 12 |
| 2009 | 13 | 5 | 18 |
| 2010 | 10 | 14 | 24 |
| 2011 | 8 | 8 | 16 |
| 2012 | 8 | 10 | 18 |
| 2013 | 5 | 7 | 12 |
| 2014 | 4 | 9 | 13 |
| 2015 | 8 | 11 | 19 |
| 2016 | 8 | 5 | 13 |
| 2017 | 8 | 19 | 27 |
| 2018 | 6 | 9 | 15 |
| 2019 | 12 | 11 | 23 |
| 2020 | 7 | 3 | 10 |
| 2021 | 13 | 4 | 17 |
| 2022 | 12 | 4 | 16 |
| 2023 | 16 | 2 | 18 |
Below are the most recent publications written about "Neutropenia" by people in Profiles.
-
How I manage inpatient consultations for quantitative neutrophil abnormalities in adults. Blood. 2023 08 31; 142(9):786-793.
-
Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma. N Engl J Med. 2023 Sep 14; 389(11):1009-1022.
-
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel. Blood Cancer J. 2023 08 01; 13(1):116.
-
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia. N Engl J Med. 2023 Jul 06; 389(1):33-44.
-
Novel BCL-2 Inhibitor Lisaftoclax in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematologic Malignancies: First-in-Human Open-Label Trial. Clin Cancer Res. 2023 07 05; 29(13):2385-2393.
-
Efficient granulocyte collection method using high concentrations of medium molecular weight hydroxyethyl starch. Transfusion. 2023 07; 63(7):1344-1353.
-
G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans. J Immunother Cancer. 2023 06; 11(6).
-
JAGN1 mutation with distinct clinical features; two case reports and literature review. BMC Pediatr. 2023 04 29; 23(1):206.
-
Dynamin-2 deficiency causes age- and sex-dependent neutropenia and myelodysplasia in mice. Blood Adv. 2023 04 25; 7(8):1418-1431.
-
Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B. Clin Cancer Res. 2023 04 14; 29(8):1477-1483.